Showing results (181-190 of 212) with videos related to
Sort By:
Pageof 22
Digestive Diseases and Sciences|October 16, 2013
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infectionJ P Gisbert, A Perez-Aisa, L Rodrigo, et al.Gut|October 7, 2016
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus ReportP Malfertheiner, F Megraud, C A O'Morain, et al.Human Immunology|October 15, 2013
Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximabL M Medrano, C Taxonera, A Márquez, et al.Alimentary Pharmacology & Therapeutics|December 8, 2010
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximabC Taxonera, J Estellés, I Fernández-Blanco, et al.Alimentary Pharmacology & Therapeutics|November 25, 2015
Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis GroupF Fernández-Bañares, M J Casanova, Y Arguedas, et al.Revista Espanola De Enfermedades Digestivas|July 3, 2004
Predictors of response to infliximab in patients with fistulizing Crohn's diseaseM Luna-Chadid, J L Pérez Calle, J L Mendoza, et al.Alimentary Pharmacology & Therapeutics|December 7, 2011
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre studyM Chaparro, P Burgueño, E Iglesias, et al.Journal of Crohn'S & Colitis|September 11, 2013
Disease severity in familial cases of IBDM Andreu, L Márquez, E Domènech, et al.Biochemical Pharmacology|September 25, 2016
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximabB Hernández-Breijo, M Chaparro, D Cano-Martínez, et al.Digestive Diseases and Sciences|September 13, 2013
Health care costs of complex perianal fistula in Crohn's diseaseM Chaparro, C Zanotti, P Burgueño, et al.Pageof 22